{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:59:23Z","timestamp":1780750763794,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer US","isbn-type":[{"value":"9781071647295","type":"print"},{"value":"9781071647301","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4730-1_9","type":"book-chapter","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T13:01:25Z","timestamp":1753707685000},"page":"143-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient"],"prefix":"10.1007","author":[{"given":"Akinori","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tsoumpra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin\u2019ichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"S343","DOI":"10.3233\/JND-210682","volume":"8","author":"S Takeda","year":"2021","unstructured":"Takeda S, Clemens PR, Hoffman EP (2021) Exon-skipping in Duchenne muscular dystrophy. J Neuromuscul Dis 8:S343\u2013S358","journal-title":"J Neuromuscul Dis"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/13543784.2021.1868434","volume":"30","author":"O Sheikh","year":"2021","unstructured":"Sheikh O, Yokota T (2021) Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Developing DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies. Expert Opin Investig Drugs 30:167\u2013176","journal-title":"Expert Opin Investig Drugs"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2174\/156652312800840621","volume":"12","author":"V Arechavala-Gomeza","year":"2012","unstructured":"Arechavala-Gomeza V, Anthony K, Morgan J, Muntoni F (2012) Antisense oligonucleotide-mediated exon skipping for Duchenne muscular dystrophy: progress and challenges. Curr Gene Ther 12:152\u2013160","journal-title":"Curr Gene Ther"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/archneurol.2008.540","volume":"66","author":"T Yokota","year":"2009","unstructured":"Yokota T, Takeda S, Lu QL et al (2009) A renaissance for antisense oligonucleotide drugs in neurology: exon skipping breaks new ground. Arch Neurol 66:32\u201338","journal-title":"Arch Neurol"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts TC, Langer R, Wood MJA (2020) Advances in oligonucleotide drug delivery. Nat Rev Drug Discov 19:673\u2013694","journal-title":"Nat Rev Drug Discov"},{"key":"9_CR6","first-page":"145","volume":"24","author":"Y Shimatsu","year":"2005","unstructured":"Shimatsu Y, Yoshimura M, Yuasa K et al (2005) Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ. Acta Myol 24:145\u2013154","journal-title":"Acta Myol"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0888-7543(92)90210-J","volume":"13","author":"N Sharp","year":"1992","unstructured":"Sharp N, Kornegay J, Van Camp S et al (1992) An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13:115\u2013121","journal-title":"Genomics"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.21627","volume":"65","author":"T Yokota","year":"2009","unstructured":"Yokota T, Lu Q, Partridge T, Kobayashi M et al (2009) Efficacy of 470 systemic morpholino exon- skipping in Duchenne dystrophy dogs. Ann Neurol 65:667\u2013676","journal-title":"Ann Neurol"},{"key":"9_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001844","volume":"3","author":"K Wee","year":"2008","unstructured":"Wee K, Pramono Z, Wang J et al (2008) Dynamics of co-480 transcriptional pre-mRNA folding influences the induction of dystrophin exon skipping by antisense oligonucleotides. PLoS One 3:e1844","journal-title":"PLoS One"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1006\/bbrc.1996.1375","volume":"226","author":"Z Pramono","year":"1996","unstructured":"Pramono Z, Takeshima Y, Alimsardjono H et al (1996) Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence. Biochem Biophys Res Commun 226:445\u2013449","journal-title":"Biochem Biophys Res Commun"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1172\/JCI115417","volume":"88","author":"J Chelly","year":"1991","unstructured":"Chelly J, Gilgenkrantz H, Hugnot J et al (1991) Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients. J Clin Invest 88:1161\u20131166","journal-title":"J Clin Invest"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/hmg\/ddg100","volume":"12","author":"A Aartsma-Rus","year":"2003","unstructured":"Aartsma-Rus A, Janson A, Kaman W et al (2003) Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. Hum Mol Genet 12:907\u2013914","journal-title":"Hum Mol Genet"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1086\/381039","volume":"74","author":"A Aartsma-Rus","year":"2004","unstructured":"Aartsma-Rus A, Janson A, Kaman W et al (2004) Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense. Am J Hum Genet 74:83\u201392","journal-title":"Am J Hum Genet"},{"key":"9_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012239","volume":"18","author":"T Saito","year":"2010","unstructured":"Saito T, Nakamura A, Aoki Y et al (2010) Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient. PLoS One 18:e12239","journal-title":"PLoS One"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1101\/gr.080531.108","volume":"19","author":"K Pruitt","year":"2009","unstructured":"Pruitt K, Harrow J, Harte R et al (2009) The consensus coding sequence (CCDS) project: identifying a common protein-coding gene set for the human and mouse genomes. Genome Res 19:1316\u20131323","journal-title":"Genome Res"},{"key":"9_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"F Desmet","year":"2009","unstructured":"Desmet F, Hamroun D, Lalande M et al (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37:e6717","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"9_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ymeth.2008.10.016","volume":"47","author":"D Eberli","year":"2009","unstructured":"Eberli D, Soker S, Atala A et al (2009) Optimization of human skeletal muscle precursor cell culture and myofiber formation in vitro. Methods 47(2):98\u2013103","journal-title":"Methods"}],"container-title":["Methods in Molecular Biology","Exon Skipping and Inclusion Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4730-1_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T12:05:27Z","timestamp":1780747527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4730-1_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647295","9781071647301"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4730-1_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"29 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}